KAVCAPA

Serial Number 97569422
672

Registration Progress

Application Filed
Aug 29, 2022
Under Examination
May 7, 2024
Approved for Publication
Feb 21, 2024
Published for Opposition
Mar 12, 2024
Registered

Trademark Image

KAVCAPA

Basic Information

Serial Number
97569422
Filing Date
August 29, 2022
Published for Opposition
March 12, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
672
Status Date
Jan 22, 2025
Application
Pending
Classes
005

Rights Holder

AstraZeneca AB

99
Address
Astraallén
Södertälje SE-15185
SE

Ownership History

AstraZeneca AB

Original Applicant
99
Södertälje SE

AstraZeneca AB

Owner at Publication
99
Södertälje SE

Legal Representation

Attorney
Cara M. Kearney

USPTO Deadlines

All Deadlines Cleared

All 6 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

26 events
Date Code Type Description Documents
Jan 22, 2025 RG1B O REINSTATEMENT GRANTED - REQUEST TO DELETE 1(B) FILED Loading...
Jan 21, 2025 APET A ASSIGNED TO PETITION STAFF Loading...
Dec 9, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 9, 2024 ERRS I TEAS REQUEST FOR REINSTATEMENT Loading...
Dec 9, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 8, 2024 D1BR I TEAS DELETE 1(B) BASIS RECEIVED Loading...
May 7, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 12, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 12, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 21, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 21, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 8, 2024 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
Feb 2, 2024 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Jan 26, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 24, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 24, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 24, 2024 ALIE A ASSIGNED TO LIE Loading...
Sep 5, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 23, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
May 23, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Mar 10, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 10, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 10, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 3, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 16, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 1, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

Classification

International Classes
005